TC BioPharm Plc Insiders

TC BioPharm Management Team Effectiveness

The company has return on total asset (ROA) of (0.982) % which means that it has lost $0.982 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.7704) %, meaning that it generated substantial loss on money invested by shareholders. TC BioPharm's management efficiency ratios could be used to measure how well TC BioPharm manages its routine affairs as well as how well it operates its assets and liabilities. Some institutional investors establish a significant position in pink sheets such as TC BioPharm in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of TC BioPharm, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

TC BioPharm Workforce Comparison

TC BioPharm Insider Trading

TC BioPharm Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as TC BioPharm Plc often depends on how effective the management is. TC BioPharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TCBPW management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TCBPW management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in TC BioPharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of TC BioPharm Plc. Check TC BioPharm's Beneish M Score to see the likelihood of TC BioPharm's management manipulating its earnings.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

If you are still planning to invest in TC BioPharm Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.